Clinical trial
COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications from the COR ECG Wearable
NCT06763549 is registered in ClinicalTrials.gov with Peerbridge Health, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications from the COR ECG Wearable
- Lead sponsor
- Peerbridge Health, Inc
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- November 16, 2024
- Completion date
- April 15, 2026
- Enrollment
- 15,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
apnea, obstructive, atrial enlargement, atrial fibrillation (af), cardiac output measurement, cardiac output, low, cardiomyopathies, primary, cardiopulmonary failure, conduction abnormalities, conduction defect, crt and/or icd, heart block, heart decompensation, heart failure, hfpef - heart failure with preserved ejection fraction, hfref - heart failure with reduced ejection fraction, hypercalcemia, hyperkalemia, hypertrophy, hypocalcemia, infarction, ischemic cardiovascular disease, lv dysfunction, lvf, myocardial infarction (mi), pacing, pacing induced dyssynchrony, pericarditis, qt prolongation, respiratory impedance, rsa, silent ischemia, sleep related breathing disorder, stemi, stemi (st elevation mi), stroke volume, stroke volume variation, sudden cardiac death due to cardiac arrhythmia, syncopation, syncope, valvular diseases, ventricular arrhythmia